Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells.

Dapas B, Pozzato G, Zorzet S, Capolla S, Paolo M, Scaggiante B, Coan M, Guerra C, Gnan C, Gattei V, Zanconati F, Grassi G.

Int J Pharm. 2020 Jan 25;574:118895. doi: 10.1016/j.ijpharm.2019.118895. Epub 2019 Dec 18.

PMID:
31862491
2.

Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients.

Abrami M, Maschio M, Conese M, Confalonieri M, Di Gioia S, Gerin F, Dapas B, Tonon F, Farra R, Murano E, Zanella G, Salton F, Torelli L, Grassi G, Grassi M.

Magn Reson Med. 2019 Dec 1. doi: 10.1002/mrm.28115. [Epub ahead of print]

PMID:
31788856
3.

Strategies for Delivery of siRNAs to Ovarian Cancer Cells.

Farra R, Maruna M, Perrone F, Grassi M, Benedetti F, Maddaloni M, El Boustani M, Parisi S, Rizzolio F, Forte G, Zanconati F, Cemazar M, Kamensek U, Dapas B, Grassi G.

Pharmaceutics. 2019 Oct 22;11(10). pii: E547. doi: 10.3390/pharmaceutics11100547. Review.

4.

In vitro metabolic zonation through oxygen gradient on a chip.

Tonon F, Giobbe GG, Zambon A, Luni C, Gagliano O, Floreani A, Grassi G, Elvassore N.

Sci Rep. 2019 Sep 19;9(1):13557. doi: 10.1038/s41598-019-49412-6.

5.

A rapid and specific method to simultaneously quantify eukaryotic elongation factor 1A1 and A2 protein levels in cancer cells.

Bosutti A, Kalaja O, Zanconati F, Dapas B, Grassi G, Passamonti S, Scaggiante B.

J Pharm Biomed Anal. 2019 Nov 30;176:112814. doi: 10.1016/j.jpba.2019.112814. Epub 2019 Aug 17.

PMID:
31450069
6.

The remarkable three-dimensional network structure of bacterial cellulose for tissue engineering applications.

Halib N, Ahmad I, Grassi M, Grassi G.

Int J Pharm. 2019 Jul 20;566:631-640. doi: 10.1016/j.ijpharm.2019.06.017. Epub 2019 Jun 10. Review.

PMID:
31195074
7.

Theoretical Importance of PVP-Alginate Hydrogels Structure on Drug Release Kinetics.

Abrami M, Marizza P, Zecchin F, Bertoncin P, Marson D, Lapasin R, de Riso F, Posocco P, Grassi G, Grassi M.

Gels. 2019 Apr 18;5(2). pii: E22. doi: 10.3390/gels5020022.

8.

E2F1 as a molecular drug target in ovarian cancer.

Farra R, Dapas B, Grassi M, Benedetti F, Grassi G.

Expert Opin Ther Targets. 2019 Mar;23(3):161-164. doi: 10.1080/14728222.2019.1579797. Epub 2019 Feb 8. No abstract available.

PMID:
30724632
9.

Antibacterial drug release from a biphasic gel system: Mathematical modelling.

Abrami M, Golob S, Pontelli F, Chiarappa G, Grassi G, Perissutti B, Voinovich D, Halib N, Murena L, Milcovich G, Grassi M.

Int J Pharm. 2019 Mar 25;559:373-381. doi: 10.1016/j.ijpharm.2019.01.055. Epub 2019 Feb 2.

PMID:
30716402
10.

Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects.

Russo Spena C, De Stefano L, Poli G, Granchi C, El Boustani M, Ecca F, Grassi G, Grassi M, Canzonieri V, Giordano A, Tuccinardi T, Caligiuri I, Rizzolio F.

J Cell Physiol. 2019 Jan 29. doi: 10.1002/jcp.28224. [Epub ahead of print]

PMID:
30697729
11.

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity.

Biolo G, Di Girolamo FG, McDonnell A, Fiotti N, Mearelli F, Situlin R, Gonelli A, Dapas B, Giordano M, Lainscak M, Grassi G, Zauli G, Secchiero P, Mekjavic I.

Front Physiol. 2018 Jul 30;9:1000. doi: 10.3389/fphys.2018.01000. eCollection 2018.

12.

Combined Used of Rheology and LF-NMR for the Characterization of PVP-Alginates Gels Containing Liposomes.

Fanesi G, Abrami M, Zecchin F, Giassi I, Ferro ED, Boisen A, Grassi G, Bertoncin P, Grassi M, Marizza P.

Pharm Res. 2018 Jul 2;35(9):171. doi: 10.1007/s11095-018-2427-0.

PMID:
29967941
13.

Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases.

Mazzaro C, Maso LD, Mauro E, Gattei V, Ghersetti M, Bulian P, Moratelli G, Grassi G, Zorat F, Pozzato G.

Diseases. 2018 May 3;6(2). pii: E35. doi: 10.3390/diseases6020035.

14.

Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness.

Farra R, Musiani F, Perrone F, Čemažar M, Kamenšek U, Tonon F, Abrami M, Ručigaj A, Grassi M, Pozzato G, Bonazza D, Zanconati F, Forte G, El Boustani M, Scarabel L, Garziera M, Russo Spena C, De Stefano L, Salis B, Toffoli G, Rizzolio F, Grassi G, Dapas B.

Molecules. 2018 Mar 28;23(4). pii: E777. doi: 10.3390/molecules23040777. Review.

15.

A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients.

Abrami M, Ascenzioni F, Di Domenico EG, Maschio M, Ventura A, Confalonieri M, Di Gioia S, Conese M, Dapas B, Grassi G, Grassi M.

Magn Reson Med. 2018 Apr;79(4):2323-2331. doi: 10.1002/mrm.26876. Epub 2017 Aug 22.

PMID:
28833401
16.

Potential Applications of Nanocellulose-Containing Materials in the Biomedical Field.

Halib N, Perrone F, Cemazar M, Dapas B, Farra R, Abrami M, Chiarappa G, Forte G, Zanconati F, Pozzato G, Murena L, Fiotti N, Lapasin R, Cansolino L, Grassi G, Grassi M.

Materials (Basel). 2017 Aug 21;10(8). pii: E977. doi: 10.3390/ma10080977. Review.

17.

Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot.

Milcovich G, Lettieri S, Antunes FE, Medronho B, Fonseca AC, Coelho JFJ, Marizza P, Perrone F, Farra R, Dapas B, Grassi G, Grassi M, Giordani S.

Adv Colloid Interface Sci. 2017 Nov;249:163-180. doi: 10.1016/j.cis.2017.05.009. Epub 2017 May 9. Review.

PMID:
28527520
18.

Modulating carbohydrate-based hydrogels as viscoelastic lubricant substitute for articular cartilages.

Milcovich G, Antunes FE, Farra R, Grassi G, Grassi M, Asaro F.

Int J Biol Macromol. 2017 Sep;102:796-804. doi: 10.1016/j.ijbiomac.2017.04.079. Epub 2017 Apr 24.

PMID:
28450242
19.

Editorial: New Trends in Gene Therapy: Multidisciplinary Approaches to siRNAs Controlled Delivery.

Barba AA, Grassi M, Grassi G, Lamberti G.

Curr Drug Deliv. 2017;14(2):156-157. doi: 10.2174/156720181402170202202808. No abstract available.

PMID:
28332452
20.

Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.

Scarabel L, Perrone F, Garziera M, Farra R, Grassi M, Musiani F, Russo Spena C, Salis B, De Stefano L, Toffoli G, Rizzolio F, Tonon F, Abrami M, Chiarappa G, Pozzato G, Forte G, Grassi G, Dapas B.

Expert Opin Drug Deliv. 2017 Jun;14(6):797-810. doi: 10.1080/17425247.2017.1292247. Epub 2017 Feb 17. Review.

PMID:
28266887

Supplemental Content

Loading ...
Support Center